npj Digital Medicine (Jun 2022)

International electronic health record-derived post-acute sequelae profiles of COVID-19 patients

  • Harrison G. Zhang,
  • Arianna Dagliati,
  • Zahra Shakeri Hossein Abad,
  • Xin Xiong,
  • Clara-Lea Bonzel,
  • Zongqi Xia,
  • Bryce W. Q. Tan,
  • Paul Avillach,
  • Gabriel A. Brat,
  • Chuan Hong,
  • Michele Morris,
  • Shyam Visweswaran,
  • Lav P. Patel,
  • Alba Gutiérrez-Sacristán,
  • David A. Hanauer,
  • John H. Holmes,
  • Malarkodi Jebathilagam Samayamuthu,
  • Florence T. Bourgeois,
  • Sehi L’Yi,
  • Sarah E. Maidlow,
  • Bertrand Moal,
  • Shawn N. Murphy,
  • Zachary H. Strasser,
  • Antoine Neuraz,
  • Kee Yuan Ngiam,
  • Ne Hooi Will Loh,
  • Gilbert S. Omenn,
  • Andrea Prunotto,
  • Lauren A. Dalvin,
  • Jeffrey G. Klann,
  • Petra Schubert,
  • Fernando J. Sanz Vidorreta,
  • Vincent Benoit,
  • Guillaume Verdy,
  • Ramakanth Kavuluru,
  • Hossein Estiri,
  • Yuan Luo,
  • Alberto Malovini,
  • Valentina Tibollo,
  • Riccardo Bellazzi,
  • Kelly Cho,
  • Yuk-Lam Ho,
  • Amelia L. M. Tan,
  • Byorn W. L. Tan,
  • Nils Gehlenborg,
  • Sara Lozano-Zahonero,
  • Vianney Jouhet,
  • Luca Chiovato,
  • Bruce J. Aronow,
  • Emma M. S. Toh,
  • Wei Gen Scott Wong,
  • Sara Pizzimenti,
  • Kavishwar B. Wagholikar,
  • Mauro Bucalo,
  • The Consortium for Clinical Characterization of COVID-19 by EHR (4CE),
  • Tianxi Cai,
  • Andrew M. South,
  • Isaac S. Kohane,
  • Griffin M. Weber

DOI
https://doi.org/10.1038/s41746-022-00623-8
Journal volume & issue
Vol. 5, no. 1
pp. 1 – 11

Abstract

Read online

Abstract The risk profiles of post-acute sequelae of COVID-19 (PASC) have not been well characterized in multi-national settings with appropriate controls. We leveraged electronic health record (EHR) data from 277 international hospitals representing 414,602 patients with COVID-19, 2.3 million control patients without COVID-19 in the inpatient and outpatient settings, and over 221 million diagnosis codes to systematically identify new-onset conditions enriched among patients with COVID-19 during the post-acute period. Compared to inpatient controls, inpatient COVID-19 cases were at significant risk for angina pectoris (RR 1.30, 95% CI 1.09–1.55), heart failure (RR 1.22, 95% CI 1.10–1.35), cognitive dysfunctions (RR 1.18, 95% CI 1.07–1.31), and fatigue (RR 1.18, 95% CI 1.07–1.30). Relative to outpatient controls, outpatient COVID-19 cases were at risk for pulmonary embolism (RR 2.10, 95% CI 1.58–2.76), venous embolism (RR 1.34, 95% CI 1.17–1.54), atrial fibrillation (RR 1.30, 95% CI 1.13–1.50), type 2 diabetes (RR 1.26, 95% CI 1.16–1.36) and vitamin D deficiency (RR 1.19, 95% CI 1.09–1.30). Outpatient COVID-19 cases were also at risk for loss of smell and taste (RR 2.42, 95% CI 1.90–3.06), inflammatory neuropathy (RR 1.66, 95% CI 1.21–2.27), and cognitive dysfunction (RR 1.18, 95% CI 1.04–1.33). The incidence of post-acute cardiovascular and pulmonary conditions decreased across time among inpatient cases while the incidence of cardiovascular, digestive, and metabolic conditions increased among outpatient cases. Our study, based on a federated international network, systematically identified robust conditions associated with PASC compared to control groups, underscoring the multifaceted cardiovascular and neurological phenotype profiles of PASC.